We really need to look into the story behind this Y-to -Y 15%...

  1. 7,726 Posts.
    lightbulb Created with Sketch. 631
    We really need to look into the story behind this Y-to -Y 15% sale drop, the whole quarter is under full impact of FDA new labeling request and many speculative legal actions from the lawyers.
    The sale figure is not that bad considering all of these factors.
    Important: Axiron' market share is still consistent.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.7¢
Change
0.001(6.25%)
Mkt cap ! $6.931M
Open High Low Value Volume
1.6¢ 1.7¢ 1.6¢ $6.279K 376.7K

Buyers (Bids)

No. Vol. Price($)
3 741559 1.6¢
 

Sellers (Offers)

Price($) Vol. No.
1.7¢ 193057 2
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.